Filings
Mentions of cybersecurity increased by a CAGR of 55% in the pharmaceutical industry since 2020
Credit: Bert van Dijk/Getty images.
Powered by
The global pharmaceutical industry experienced a 55% rise in compound annual growth rate (CAGR) in company filings mentions of cybersecurity since 2020. Key companies in terms of mentions include BeiGene, Denali Therapeutics, and Akebia Therapeutics, according to GlobalData’s analysis of over 6,000 pharmaceutical company filings.
Notably, since 2020, cybersecurity was the most referenced theme in terms of mentions, ahead of big data, cloud and artificial intelligence, according to GlobalData's Company Filings database. Mentions related to cybersecurity increased by 58% year-on-year in 2021 and by 53% year-on-year in 2022.
Top five companies by mentions of cybersecurity in the global pharmaceutical industry since 2020
Of the 50 leading companies in the pharmaceutical industry, Compass Pathways had the highest year-on-year increase in references to cybersecurity in 2022. GlobalData identified 192 cybersecurity related sentences in the company's filings in 2022, 1% of all sentences. Meanwhile, Immunovant had the highest year-on-year increase in references for cybersecurity in 2021. GlobalData identified 94 cybersecurity related sentences in the company's filings in 2021, 1% of all sentences.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
Global Data’s Company Filings Analytics uses machine learning to uncover key insights and track sentiment across millions of regulatory filings and other corporate disclosures for thousands of companies across the world’s largest industries.
